When a patient is diagnosed with colorectal cancer, the path forward can feel overwhelming. Doctors use clinical practice guidelines to decide the best way to treat the disease. A review of 30 different studies looked at whether following these specific guidelines actually helped patients live longer.
The data showed a clear benefit for patients with Stage II and Stage III colon cancer who received treatment that followed these guidelines. For these specific stages, following the rules led to a significant survival advantage. However, the results were not as clear for other types of tumors or for rectal cancer, where the data showed a trend but was not statistically certain.
It is important to note that this study looked at existing records rather than a controlled trial. The researchers also found that things like a patient's age, background, and the type of medical facility can create barriers to following these guidelines. Because the data for overall survival across all sites was very varied, the results are most certain for those with Stage II and III colon cancer.
